A dual-targeted multifunctional nanoformulation for potential prevention and therapy of Alzheimer's disease
Antioxidation and adjustable treatment strategies are critical for the effective treatment of Alzheimer's disease (AD). Here, we design a dual-targeted Prussian blue nanoformulation (PTCN) that can cross the blood-brain barrier and target amyloid beta aggregates further exert antioxidant effect...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-11-01
|
Series: | The Innovation |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666675821000850 |